成人弥漫性中线胶质瘤H3 K27变异型:重新定义实体的综述
本文综述成人弥漫性中线胶质瘤H3 K27变异型的遗传、临床、影像特征及管理。2021年WHO分类将既往H3 K27M突变型更名为H3 K27变异型,诊断标准为弥漫性生长、中线解剖位置及H3 K27特异性神经胶质突变。成人患者中位生存期9至12个月,未来需进一步研究细化该年龄组特征。
要点
- 2021年WHO分类将DMG H3 K27M突变型更名为DMG H3 K27变异型,涵盖其他致病机制。
- 诊断标准为弥漫性生长模式、中线解剖位置及H3 K27特异性神经胶质突变。
- 成人患者中位生存期9至12个月,中线位置导致手术切除和活检困难,死亡率和致残率高。
核心结论
- 成人DMG H3 K27变异型的诊断应在神经系统症状伴影像学发现浸润性中线脑肿瘤时考虑。
- 未来研究有必要继续细化该年龄组DMG H3 K27变异型的特征。
研究设计与样本
- 本文为对当前文献的综述,检索范围涉及成人弥漫性中线胶质瘤H3 K27变异型的遗传、临床、影像特征及管理。
主要发现
- 2021年WHO分类将既往识别的DMG H3K27M突变型命名为DMG H3 K27变异型,认可致病通路可经替代机制发生改变。
- 成人患者中位生存期范围为9至12个月。
关键数值与推荐
- 诊断标准包括弥漫性生长模式、中线解剖位置及H3 K27特异性神经胶质突变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Diffuse midline glioma (DMG) H3 K27-altered is a type of high-grade gliomas first recognized as a new entity in the 2016 World Health Organization Classification of Central Nervous System (CNS) Tumors as DMG H3 K27M-mutant, recently renamed in the new 2021 WHO classification. The aim of this review is to describe the characteristics of diffuse midline gliomas H3 K27-altered in the adult population. METHODS: We performed a review of the current literature regarding the genetic, clinical, imaging characteristics and management of diffuse midline gliomas H3 K27-altered in adult patients. RESULTS: The 2021 WHO classification now designates the previously recognized DMG H3K27M-mutant as DMG H3 K27-altered, recognizing the alternative mechanisms by which the pathogenic pathway can be altered. Thus, the diagnostic criteria for this entity consist of diffuse growth pattern, midline anatomic location, and H3 K27-specific neuroglial mutations. DMGs' characteristic midline location makes them difficult to surgically resect and biopsy, carrying high mortality and morbidity rates, with median survival ranging from 9 to 12 months in adult patients. CONCLUSION: The diagnosis of DMGs H3 K27-altered in adult patients should be considered upon neurological symptoms associated with an infiltrative midline brain tumor detected on imaging. Future studies are necessary to continue refining their characteristics in this age group.
引用
- López-Pérez CA, Franco-Mojica X, Villanueva-Gaona R, et al. Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity. J Neurooncol. 2022. PMID: 35567713. doi:10.1007/s11060-022-04024-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。